Table 4 Total societal costs by trial allocation and cost component category for the entire follow-up period in imputed analysis (£, 2018–19 prices)
Cost category | Treatment arm, mean cost (£) (SE) | Mean cost (£) difference | p-value i | 95% confidence interval | |
|---|---|---|---|---|---|
BOOST programme | Best practice advice (BPA) | ||||
(n = 292) | (n = 143) | ||||
NHS and PSS (including intervention costs) | 1974.06 (118.05) | 1826.64 (168.70) | 147.42 | 0.474 | (− 419.00 to 714.00) |
Societal | |||||
Privately provided health services | 14.24 (5.15) | 8.32 (7.37) | 5.91 | 0.511 | (− 11.76 to 23.59) |
Medications | 5.53 (0.88) | 7.01 (1.26) | − 1.48 | 0.335 | (− 4.49 to 1.53) |
Patient equipment | 21.17 (8.94) | 26.93 (12.78) | − 5.75 | 0.712 | (− 36.41 to 24.91) |
Patient travel | 13.91 (2.18) | 20.86 (3.11) | − 6.96 | 0.068 | (− 14.42 to 0.51) |
Time off work | 33.50 (29.74) | 100.49 (42.50) | − 66.99 | 0.197 | (− 168.95 to 34.96) |
Other Societal Costs | 113.60 (46.69) | 150.29 (66.73) | − 36.68 | 0.653 | (− 196.77 to 123.40) |
Societal (excluding NHS and PSS costs) | 201.94 (68.80) | 313.90 (98.32) | − 111.95 | 0.351 | (− 347.82 to 123.92) |
Total Societal (including NHS and PSS and intervention costs) | 2176.01 (145.13) | 2140.54 (207.40) | 35.47 | 0.889 | (− 469.57 to 540.51) |